DuPont Expands Animal Health Solutions Busine... (disinfectant agent available. It works ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

DuPont Expands Animal Health Solutions Business in Asia

Date:5/19/2008

disinfectant agent available. It works as a preventive measure,

enhancing sanitary conditions of livestock areas and helping to

prevent avian influenza from spreading.

SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
2. DuPont Strengthens Commitment to Responsible Science with New Biotech Advisory Panel Members
3. DuPont Partnering with China to Increase Farm Productivity
4. DuPont Reports First Quarter Earnings Growth of Over 20 Percent
5. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
6. DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development
7. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
8. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
9. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
10. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
11. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize

Post Your Comments:

Breaking Biology Technology:Successful Stem Cell Therapy for Treatment of Eye Disease 2 Successful Stem Cell Therapy for Treatment of Eye Disease 3 Successful Stem Cell Therapy for Treatment of Eye Disease 4 Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2 Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3 Dendreon Appoints Hans Bishop as Chief Operating Officer 2 La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2 La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3

[0] Successful Stem Cell Therapy for Treatment of Eye Disease [0] Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products [0] Dendreon Appoints Hans Bishop as Chief Operating Officer [0] La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert

Other Biology Technology:Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility 2 WTN Interview: Roberta Gassman 2 WTN Interview: Roberta Gassman 3 High-Tech Economic Development in Southeastern Wisconsin 2 High-Tech Economic Development in Southeastern Wisconsin 3

Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility WTN Interview: Roberta Gassman High-Tech Economic Development in Southeastern Wisconsin

Breaking Biology News(10 mins):UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2 University of California, San Francisco, researcher receives ASBMB-Merck Award 2 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 1 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 2 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 3 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 4 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 5 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 6 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 7 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 8 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 9 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 10 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 11 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 12 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 13 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 14 CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 15 Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 1 Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 2 Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 3 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 1 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 2 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 3 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 4 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 5 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 6 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 7 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 8 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 9 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 10 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 11 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 12 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 13 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 14 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 15

[0] Lehigh University professor receives Astellas Award for arsenic groundwater remediation efforts [0] UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel [0] University of California, San Francisco, researcher receives ASBMB-Merck Award

Other Biology News:bioMETRX Incorporates OKI's Fingerprint Engine in its smartTOUCH Product Line 2 bioMETRX Incorporates OKI's Fingerprint Engine in its smartTOUCH Product Line 3 Gene's 'selective signature' aids detection of natural selection in microbial evolution 2 Gene's 'selective signature' aids detection of natural selection in microbial evolution 3 Solving an avian scourge could also provide benefits to human health 2 Solving an avian scourge could also provide benefits to human health 3

bioMETRX Incorporates OKI's Fingerprint Engine in its smartTOUCH Product Line Gene's 'selective signature' aids detection of natural selection in microbial evolution Solving an avian scourge could also provide benefits to human health

Biology Products:

Goat Anti-MLH3 Polyclonal Antibody, Unconjugated from Abcam Rabbit Anti-Human IRF7 Antibody, Unconjugated from ABR-Affinity BioReagents Mouse Anti-DNA-PKcs, phospho (Thr2609) Monoclonal Antibody, Unconjugated, Clone 10B1 from BioLegend Rabbit Anti-Coronin / CORO1C Polyclonal Antibody, Unconjugated from IMGENEX